Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Conduit Pharmaceuticals ( (CDT) ) has shared an announcement.
On May 5, 2025, Conduit Pharmaceuticals Inc. held a special meeting of stockholders where a quorum was achieved with proxies representing over one-third of the company’s common stock. During the meeting, stockholders approved amendments to the company’s Certificate of Incorporation to allow for reverse stock splits at ratios determined by the board of directors. This decision could potentially impact the company’s stock structure and market perception.
More about Conduit Pharmaceuticals
Average Trading Volume: 5,766,367
Technical Sentiment Signal: Sell
Current Market Cap: $6.09M
Learn more about CDT stock on TipRanks’ Stock Analysis page.